hu.MAP 3.0: Complex View
Human Protein Complex Map
Search for a protein
Complex: huMAP3_12069.1
Complex Portal: CPX-21203
Confidence: Medium  
ProteinsGenename | Protein Name | Uniprot Annotation Score | Links |
---|---|---|---|
SDHAF3 | Succinate dehydrogenase assembly factor 3, mitochondrial (SDH assembly factor 3) (SDHAF3) | 2 | UniProt   NCBI |
SDHAF2 | Succinate dehydrogenase assembly factor 2, mitochondrial (SDH assembly factor 2) (SDHAF2) | 5 | UniProt   NCBI |
HGF | Hepatocyte growth factor (Hepatopoietin-A) (Scatter factor) (SF) [Cleaved into: Hepatocyte growth factor alpha chain; Hepatocyte growth factor beta chain] | 5 | UniProt   NCBI |
SDHAF4 | Succinate dehydrogenase assembly factor 4, mitochondrial (SDH assembly factor 4) (SDHAF4) | 4 | UniProt   NCBI |
SDHB | Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial (EC 1.3.5.1) (Iron-sulfur subunit of complex II) (Ip) | 5 | UniProt   NCBI |
SDHA | Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial (EC 1.3.5.1) (Flavoprotein subunit of complex II) (Fp) | 5 | UniProt   NCBI |
SDHC | Succinate dehydrogenase cytochrome b560 subunit, mitochondrial (Integral membrane protein CII-3) (QPs-1) (QPs1) (Succinate dehydrogenase complex subunit C) (Succinate-ubiquinone oxidoreductase cytochrome B large subunit) (CYBL) | 5 | UniProt   NCBI |
DHODH | Dihydroorotate dehydrogenase (quinone), mitochondrial (DHOdehase) (EC 1.3.5.2) (Dihydroorotate oxidase) | 5 | UniProt   NCBI |
TMEM95 | Sperm-egg fusion protein TMEM95 (Transmembrane protein 95) | 4 | UniProt   NCBI |
SDHD | Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial (CybS) (CII-4) (QPs3) (Succinate dehydrogenase complex subunit D) (Succinate-ubiquinone oxidoreductase cytochrome b small subunit) (Succinate-ubiquinone reductase membrane anchor subunit) | 5 | UniProt   NCBI |
Enrichments
Term ID | Corrected Pval | Fraction Complex Coverage | Proteins | Term Name |
---|---|---|---|---|
  WP:WP4920 | 5.28918727849e-18 | 0.75 | SDHD SDHAF4 SDHAF2 SDHC SDHAF3 SDHA | Mitochondrial complex II assembly |
  HP:0001686 | 4.76140718857e-10 | 0.5 | SDHAF2 SDHD SDHA SDHC | Loss of voice |
  GO:0006121 | 9.20740386965e-09 | 0.5 | SDHAF2 SDHD SDHA SDHC | mitochondrial electron transport, succinate to ubiquinone |
  HP:0002864 | 4.32434495125e-08 | 0.5 | SDHAF2 SDHD SDHA SDHC | Paraganglioma of head and neck |
  HP:0000740 | 4.32434495125e-08 | 0.5 | SDHAF2 SDHD SDHA SDHC | Episodic paroxysmal anxiety |
  HP:0002640 | 4.32434495125e-08 | 0.5 | SDHAF2 SDHD SDHA SDHC | Hypertension associated with pheochromocytoma |
  HP:0009711 | 4.32434495125e-08 | 0.5 | SDHAF2 SDHD SDHA SDHC | Retinal capillary hemangioma |
  HP:0008629 | 4.32434495125e-08 | 0.5 | SDHAF2 SDHD SDHA SDHC | Pulsatile tinnitus |
  HP:0003345 | 4.32434495125e-08 | 0.5 | SDHAF2 SDHD SDHA SDHC | Elevated urinary norepinephrine level |
  HP:0011979 | 4.32434495125e-08 | 0.5 | SDHAF2 SDHD SDHA SDHC | Elevated urinary dopamine level |
  HP:0003574 | 4.32434495125e-08 | 0.5 | SDHAF2 SDHD SDHA SDHC | Positive regitine blocking test |
  HP:0003639 | 4.32434495125e-08 | 0.5 | SDHAF2 SDHD SDHA SDHC | Elevated urinary epinephrine level |
  HP:0012222 | 4.32434495125e-08 | 0.5 | SDHAF2 SDHD SDHA SDHC | Arachnoid hemangiomatosis |
  HP:0006737 | 4.32434495125e-08 | 0.5 | SDHAF2 SDHD SDHA SDHC | Extraadrenal pheochromocytoma |
  HP:0006748 | 5.76452981851e-08 | 0.5 | SDHAF2 SDHD SDHA SDHC | Adrenal pheochromocytoma |
  HP:0010532 | 5.76452981851e-08 | 0.5 | SDHAF2 SDHD SDHA SDHC | Paroxysmal vertigo |
  HP:0100642 | 5.76452981851e-08 | 0.5 | SDHAF2 SDHD SDHA SDHC | Neoplasm of the adrenal medulla |
  HP:0010797 | 7.53657938041e-08 | 0.5 | SDHAF2 SDHD SDHA SDHC | Hemangioblastoma |
  HP:0001095 | 7.53657938041e-08 | 0.5 | SDHAF2 SDHD SDHA SDHC | Hypertensive retinopathy |
  HP:0002668 | 9.6877642404e-08 | 0.5 | SDHAF2 SDHD SDHA SDHC | Paraganglioma |
  HP:0011976 | 1.53322372488e-07 | 0.5 | SDHAF2 SDHD SDHA SDHC | Elevated urinary catecholamine level |
  HP:0011281 | 1.53322372488e-07 | 0.5 | SDHAF2 SDHD SDHA SDHC | Abnormality of urine catecholamine level |
  HP:0003528 | 1.53322372488e-07 | 0.5 | SDHAF2 SDHD SDHA SDHC | Elevated circulating calcitonin concentration |
  HP:0034902 | 1.53322372488e-07 | 0.5 | SDHAF2 SDHD SDHA SDHC | Abnormal circulating calcitonin concentration |
  HP:0009594 | 1.89356712338e-07 | 0.5 | SDHAF2 SDHD SDHA SDHC | Retinal hamartoma |
  HP:0002331 | 2.80036539718e-07 | 0.5 | SDHAF2 SDHD SDHA SDHC | Recurrent paroxysmal headache |
  HP:0011703 | 3.35970182629e-07 | 0.5 | SDHAF2 SDHD SDHA SDHC | Sinus tachycardia |
  HP:0030074 | 3.71126957735e-07 | 0.375 | SDHAF2 SDHC SDHD | Chemodectoma |
  HP:0010568 | 3.99876821683e-07 | 0.5 | SDHAF2 SDHD SDHA SDHC | Hamartoma of the eye |
  HP:0030670 | 3.99876821683e-07 | 0.5 | SDHAF2 SDHD SDHA SDHC | Hamartoma of the orbital region |
  HP:0001069 | 3.99876821683e-07 | 0.5 | SDHAF2 SDHD SDHA SDHC | Episodic hyperhidrosis |
  HP:0002666 | 4.72478092576e-07 | 0.5 | SDHAF2 SDHD SDHA SDHC | Pheochromocytoma |
  HP:0002574 | 8.6534513212e-07 | 0.5 | SDHAF2 SDHD SDHA SDHC | Episodic abdominal pain |
  HP:0003001 | 9.27579271823e-07 | 0.375 | SDHAF2 SDHC SDHD | Glomus jugular tumor |
  HP:0032148 | 1.13498137973e-06 | 0.5 | SDHAF2 SDHD SDHA SDHC | Episodic pain |
  HP:0100530 | 1.29124729367e-06 | 0.5 | SDHAF2 SDHD SDHA SDHC | Abnormal circulating calcium-phosphate regulating hormone concentration |
  HP:0100634 | 1.46309264702e-06 | 0.5 | SDHAF2 SDHD SDHA SDHC | Neuroendocrine neoplasm |
  HP:0000526 | 2.59204993656e-06 | 0.5 | SDHAF2 SDHD SDHA SDHC | Aniridia |
  HP:0100631 | 2.87942365626e-06 | 0.5 | SDHAF2 SDHD SDHA SDHC | Neoplasm of the adrenal gland |
  HP:0100012 | 3.88571869614e-06 | 0.5 | SDHAF2 SDHD SDHA SDHC | Neoplasm of the eye |
  HP:0031801 | 3.88571869614e-06 | 0.5 | SDHAF2 SDHD SDHA SDHC | Vocal cord dysfunction |
  HP:0001605 | 3.88571869614e-06 | 0.5 | SDHAF2 SDHD SDHA SDHC | Vocal cord paralysis |
  HP:0001293 | 3.88571869614e-06 | 0.5 | SDHAF2 SDHD SDHA SDHC | Cranial nerve compression |
  HP:0031284 | 4.27335268869e-06 | 0.5 | SDHAF2 SDHD SDHA SDHC | Flushing |
  HP:0025269 | 7.2401525095e-06 | 0.5 | SDHAF2 SDHD SDHA SDHC | Panic attack |
  WP:WP78 | 7.98434088212e-06 | 0.375 | SDHD SDHA SDHC | TCA cycle aka Krebs or citric acid cycle |
  HP:0000360 | 9.93354606521e-06 | 0.5 | SDHAF2 SDHD SDHA SDHC | Tinnitus |
  HP:0010566 | 1.23992213916e-05 | 0.5 | SDHAF2 SDHD SDHA SDHC | Hamartoma |
  HP:0001342 | 1.23992213916e-05 | 0.5 | SDHAF2 SDHD SDHA SDHC | Cerebral hemorrhage |
  HP:0003072 | 1.33147580685e-05 | 0.5 | SDHAF2 SDHD SDHA SDHC | Hypercalcemia |
  HP:0100007 | 1.63664569014e-05 | 0.5 | SDHAF2 SDHD SDHA SDHC | Neoplasm of the peripheral nervous system |
  HP:0001291 | 1.63664569014e-05 | 0.5 | SDHAF2 SDHD SDHA SDHC | Abnormal cranial nerve morphology |
  HP:0005584 | 1.86730872519e-05 | 0.5 | SDHAF2 SDHD SDHA SDHC | Renal cell carcinoma |
  GO:0006099 | 1.94862705925e-05 | 0.5 | SDHAF2 SDHD SDHA SDHC | tricarboxylic acid cycle |
  HP:0011702 | 1.99135850848e-05 | 0.5 | SDHAF2 SDHD SDHA SDHC | Abnormal electrophysiology of sinoatrial node origin |
  KEGG:00020 | 2.14879728377e-05 | 0.375 | SDHD SDHA SDHC | Citrate cycle (TCA cycle) |
  GO:0045281 | 2.15253635486e-05 | 0.375 | SDHD SDHA SDHC | succinate dehydrogenase complex |
  GO:0045283 | 2.15253635486e-05 | 0.375 | SDHD SDHA SDHC | fumarate reductase complex |
  GO:0034552 | 2.15253635486e-05 | 0.375 | SDHAF3 SDHAF4 SDHAF2 | respiratory chain complex II assembly |
  GO:0045273 | 2.15253635486e-05 | 0.375 | SDHD SDHA SDHC | respiratory chain complex II |
  GO:0045257 | 2.15253635486e-05 | 0.375 | SDHD SDHA SDHC | succinate dehydrogenase complex (ubiquinone) |
  GO:0005749 | 2.15253635486e-05 | 0.375 | SDHD SDHA SDHC | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone) |
  GO:0034553 | 2.15253635486e-05 | 0.375 | SDHAF3 SDHAF4 SDHAF2 | mitochondrial respiratory chain complex II assembly |
  REAC:R-HSA-71403 | 3.03234516525e-05 | 0.375 | SDHD SDHA SDHC | Citric acid cycle (TCA cycle) |
  HP:0002018 | 4.69355516597e-05 | 0.5 | SDHAF2 SDHD SDHA SDHC | Nausea |
  HP:0000096 | 5.19495358718e-05 | 0.5 | SDHAF2 SDHD SDHA SDHC | Glomerular sclerosis |
  HP:0001962 | 6.02080792072e-05 | 0.5 | SDHAF2 SDHD SDHA SDHC | Palpitations |
  HP:0100723 | 6.28813589663e-05 | 0.375 | SDHD SDHA SDHC | Gastrointestinal stroma tumor |
  HP:0100833 | 6.28813589663e-05 | 0.375 | SDHD SDHA SDHC | Neoplasm of the small intestine |
  HP:0031071 | 8.32696157954e-05 | 0.5 | SDHAF2 SDHD SDHA SDHC | Abnormal endocrine morphology |
  HP:0011732 | 8.32696157954e-05 | 0.5 | SDHAF2 SDHD SDHA SDHC | Abnormal adrenal morphology |
  HP:0100835 | 0.000121927901748 | 0.5 | SDHAF2 SDHD SDHA SDHC | Benign neoplasm of the central nervous system |
  HP:0100749 | 0.000132079586227 | 0.5 | SDHAF2 SDHD SDHA SDHC | Chest pain |
  HP:0000405 | 0.000170026002076 | 0.625 | SDHAF2 SDHD DHODH SDHA SDHC | Conductive hearing impairment |
  HP:0011452 | 0.000184464620703 | 0.625 | SDHAF2 SDHD DHODH SDHA SDHC | Functional abnormality of the middle ear |
  HP:0001618 | 0.000192611932556 | 0.5 | SDHAF2 SDHD SDHA SDHC | Dysphonia |
  HP:0008053 | 0.000199636300587 | 0.5 | SDHAF2 SDHD SDHA SDHC | Aplasia/Hypoplasia of the iris |
  HP:0008055 | 0.000199636300587 | 0.5 | SDHAF2 SDHD SDHA SDHC | Aplasia/Hypoplasia affecting the uvea |
  HP:0002321 | 0.000206850251961 | 0.5 | SDHAF2 SDHD SDHA SDHC | Vertigo |
  HP:0009726 | 0.000214257131294 | 0.5 | SDHAF2 SDHD SDHA SDHC | Renal neoplasm |
  HP:0006715 | 0.000226027933833 | 0.25 | SDHAF2 SDHD | Glomus tympanicum paraganglioma |
  HP:0002886 | 0.000226027933833 | 0.25 | SDHAF2 SDHD | Vagal paraganglioma |
  HP:0010786 | 0.000254304465057 | 0.5 | SDHAF2 SDHD SDHA SDHC | Urinary tract neoplasm |
  HP:0008062 | 0.000271794082941 | 0.5 | SDHAF2 SDHD SDHA SDHC | Aplasia/Hypoplasia affecting the anterior segment of the eye |
  HP:0004363 | 0.00029969273526 | 0.5 | SDHAF2 SDHD SDHA SDHC | Abnormal circulating calcium concentration |
  HP:0002170 | 0.000361842646163 | 0.5 | SDHAF2 SDHD SDHA SDHC | Intracranial hemorrhage |
  HP:0033331 | 0.000361842646163 | 0.5 | SDHAF2 SDHD SDHA SDHC | Acute phase response |
  HP:0100568 | 0.000396296239007 | 0.5 | SDHAF2 SDHD SDHA SDHC | Neoplasm of the endocrine system |
  HP:0001028 | 0.000396296239007 | 0.5 | SDHAF2 SDHD SDHA SDHC | Hemangioma |
  HP:0000980 | 0.000408306883514 | 0.5 | SDHAF2 SDHD SDHA SDHC | Pallor |
  HP:0003470 | 0.000433140852756 | 0.5 | SDHAF2 SDHD SDHA SDHC | Paralysis |
  HP:0100742 | 0.000445972109624 | 0.5 | SDHAF2 SDHD SDHA SDHC | Vascular neoplasm |
  HP:0010927 | 0.000445972109624 | 0.5 | SDHAF2 SDHD SDHA SDHC | Abnormal blood inorganic cation concentration |
  HP:0000975 | 0.000459084881468 | 0.5 | SDHAF2 SDHD SDHA SDHC | Hyperhidrosis |
  REAC:R-HSA-71406 | 0.000499872649354 | 0.375 | SDHD SDHA SDHC | Pyruvate metabolism and Citric Acid (TCA) cycle |
  GO:0045333 | 0.000530546258616 | 0.625 | SDHC SDHAF2 SDHD SDHAF4 SDHA | cellular respiration |
  HP:0012614 | 0.000767242624533 | 0.5 | SDHAF2 SDHD SDHA SDHC | Abnormal urine cytology |
  HP:0000790 | 0.000767242624533 | 0.5 | SDHAF2 SDHD SDHA SDHC | Hematuria |
  HP:0100006 | 0.000786868782586 | 0.5 | SDHAF2 SDHD SDHA SDHC | Neoplasm of the central nervous system |
  HP:0001751 | 0.000806866831728 | 0.5 | SDHAF2 SDHD SDHA SDHC | Abnormal vestibular function |
  HP:0000095 | 0.000847997020233 | 0.5 | SDHAF2 SDHD SDHA SDHC | Abnormal renal glomerulus morphology |
  HP:0031263 | 0.000869138434239 | 0.5 | SDHAF2 SDHD SDHA SDHC | Abnormal renal corpuscle morphology |
  KEGG:01200 | 0.00094562799903 | 0.375 | SDHD SDHA SDHC | Carbon metabolism |
  HP:0000834 | 0.00102832589131 | 0.5 | SDHAF2 SDHD SDHA SDHC | Abnormality of the adrenal glands |
  HP:0004375 | 0.00112851080431 | 0.5 | SDHAF2 SDHD SDHA SDHC | Neoplasm of the nervous system |
  HP:0100743 | 0.00113360622659 | 0.375 | SDHD SDHA SDHC | Neoplasm of the rectum |
  WP:WP111 | 0.00145791004127 | 0.375 | SDHD SDHA SDHC | Electron transport chain OXPHOS system in mitochondria |
  KEGG:00190 | 0.00152602370755 | 0.375 | SDHD SDHA SDHC | Oxidative phosphorylation |
  HP:0007550 | 0.00163742493148 | 0.5 | SDHAF2 SDHD SDHA SDHC | Hypohidrosis or hyperhidrosis |
  HP:0011035 | 0.00185241136758 | 0.5 | SDHAF2 SDHD SDHA SDHC | Abnormal renal cortex morphology |
  HP:0025276 | 0.00189018749295 | 0.5 | SDHAF2 SDHD SDHA SDHC | Abnormality of skin adnexa physiology |
  HP:0007379 | 0.00192853414724 | 0.5 | SDHAF2 SDHD SDHA SDHC | Neoplasm of the genitourinary tract |
  HP:0000093 | 0.00192853414724 | 0.5 | SDHAF2 SDHD SDHA SDHC | Proteinuria |
  GO:0015980 | 0.00213344193493 | 0.625 | SDHC SDHAF2 SDHD SDHAF4 SDHA | energy derivation by oxidation of organic compounds |
  KEGG:04932 | 0.0022539548616 | 0.375 | SDHD SDHA SDHC | Non-alcoholic fatty liver disease |
  GO:0019646 | 0.002326053637 | 0.5 | SDHAF2 SDHD SDHA SDHC | aerobic electron transport chain |
  HP:0000370 | 0.00244760101111 | 0.625 | SDHAF2 SDHD DHODH SDHA SDHC | Abnormality of the middle ear |
  HP:0020129 | 0.00267324865117 | 0.5 | SDHAF2 SDHD SDHA SDHC | Abnormal urine protein level |
  HP:0008046 | 0.00272284792648 | 0.5 | SDHAF2 SDHD SDHA SDHC | Abnormal retinal vascular morphology |
  HP:0012575 | 0.00277312854607 | 0.5 | SDHAF2 SDHD SDHA SDHC | Abnormal nephron morphology |
  HP:0001635 | 0.00298118645851 | 0.5 | SDHAF2 SDHD SDHA SDHC | Congestive heart failure |
  GO:0042773 | 0.00316689333881 | 0.5 | SDHAF2 SDHD SDHA SDHC | ATP synthesis coupled electron transport |
  GO:0042775 | 0.00316689333881 | 0.5 | SDHAF2 SDHD SDHA SDHC | mitochondrial ATP synthesis coupled electron transport |
  REAC:R-HSA-611105 | 0.00350506047164 | 0.375 | SDHD SDHA SDHC | Respiratory electron transport |
  WP:WP4396 | 0.00397822087206 | 0.375 | SDHD SDHA SDHC | Nonalcoholic fatty liver disease |
  HP:0005214 | 0.0043733297498 | 0.375 | SDHD SDHA SDHC | Intestinal obstruction |
  GO:0022904 | 0.00482963771614 | 0.5 | SDHAF2 SDHD SDHA SDHC | respiratory electron transport chain |
  KEGG:05415 | 0.0050295788442 | 0.375 | SDHD SDHA SDHC | Diabetic cardiomyopathy |
  HP:0010929 | 0.00584390206375 | 0.5 | SDHAF2 SDHD SDHA SDHC | Abnormal blood cation concentration |
  HP:0100780 | 0.0063183945919 | 0.25 | SDHC SDHD | Conjunctival hamartoma |
  REAC:R-HSA-163200 | 0.00639902621489 | 0.375 | SDHD SDHA SDHC | Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
  HP:0004796 | 0.00640296160267 | 0.375 | SDHD SDHA SDHC | Gastrointestinal obstruction |
  GO:0022900 | 0.00679043955679 | 0.5 | SDHAF2 SDHD SDHA SDHC | electron transport chain |
  KEGG:05208 | 0.00685237808039 | 0.375 | SDHD SDHA SDHC | Chemical carcinogenesis - reactive oxygen species |
  KEGG:04714 | 0.0071582527241 | 0.375 | SDHD SDHA SDHC | Thermogenesis |
  HP:0002027 | 0.00717720349197 | 0.5 | SDHAF2 SDHD SDHA SDHC | Abdominal pain |
  HP:0003111 | 0.00728036426446 | 0.5 | SDHAF2 SDHD SDHA SDHC | Abnormal blood ion concentration |
  HP:0002315 | 0.00792261538488 | 0.5 | SDHAF2 SDHD SDHA SDHC | Headache |
  HP:0007700 | 0.00803360911744 | 0.5 | SDHAF2 SDHD SDHA SDHC | Ocular anterior segment dysgenesis |
  HP:0003334 | 0.00812142628406 | 0.25 | SDHC SDHD | Elevated circulating catecholamine level |
  HP:0012099 | 0.00812142628406 | 0.25 | SDHC SDHD | Abnormality of circulating catecholamine level |
  HP:0003756 | 0.00812142628406 | 0.25 | SDHA SDHD | Skeletal myopathy |
  HP:0011029 | 0.00872398029061 | 0.5 | SDHAF2 SDHD SDHA SDHC | Internal hemorrhage |
  HP:0100659 | 0.00971174455567 | 0.5 | SDHAF2 SDHD SDHA SDHC | Abnormal cerebral vascular morphology |
  HP:0011792 | 0.00997111818989 | 0.5 | SDHAF2 SDHD SDHA SDHC | Neoplasm by histology |
  HP:0007272 | 0.0101490036868 | 0.25 | SDHA SDHD | Progressive psychomotor deterioration |
  HP:0011028 | 0.0110602658548 | 0.5 | SDHAF2 SDHD SDHA SDHC | Abnormality of blood circulation |
  KEGG:05012 | 0.0111289834178 | 0.375 | SDHD SDHA SDHC | Parkinson disease |
  KEGG:05020 | 0.0121225246333 | 0.375 | SDHD SDHA SDHC | Prion disease |
  HP:0008047 | 0.0131752265633 | 0.5 | SDHAF2 SDHD SDHA SDHC | Abnormality of the vasculature of the eye |
  HP:0001824 | 0.0131752265633 | 0.5 | SDHAF2 SDHD SDHA SDHC | Weight loss |
  HP:0001609 | 0.013356500578 | 0.375 | SDHAF2 SDHC SDHD | Hoarse voice |
  GO:0006119 | 0.0137848137495 | 0.5 | SDHAF2 SDHD SDHA SDHC | oxidative phosphorylation |
  GO:0005739 | 0.0144653996187 | 0.875 | DHODH SDHA SDHAF4 SDHAF2 SDHC SDHAF3 SDHD | mitochondrion |
  HP:0005595 | 0.014877056319 | 0.25 | SDHC SDHD | Generalized hyperkeratosis |
  HP:0012817 | 0.014877056319 | 0.25 | SDHA SDHD | Noncompaction cardiomyopathy |
  HP:0000822 | 0.0155758710774 | 0.5 | SDHAF2 SDHD SDHA SDHC | Hypertension |
  KEGG:05016 | 0.0163151161285 | 0.375 | SDHD SDHA SDHC | Huntington disease |
  GO:0006091 | 0.0164950268945 | 0.625 | SDHC SDHAF2 SDHD SDHAF4 SDHA | generation of precursor metabolites and energy |
  HP:0000759 | 0.0168907213853 | 0.5 | SDHAF2 SDHD SDHA SDHC | Abnormal peripheral nervous system morphology |
  HP:0003117 | 0.0172810254732 | 0.5 | SDHAF2 SDHD SDHA SDHC | Abnormal circulating hormone concentration |
  REAC:R-HSA-1428517 | 0.0173433758996 | 0.375 | SDHD SDHA SDHC | The citric acid (TCA) cycle and respiratory electron transport |
  HP:0008314 | 0.0175771621337 | 0.25 | SDHA SDHD | Decreased activity of mitochondrial complex II |
  HP:0004390 | 0.0175771621337 | 0.25 | SDHC SDHD | Hamartomatous polyposis |
  HP:0100834 | 0.0179343735586 | 0.375 | SDHD SDHA SDHC | Neoplasm of the large intestine |
  HP:0006731 | 0.020501074829 | 0.25 | SDHC SDHD | Follicular thyroid carcinoma |
  HP:0008675 | 0.020501074829 | 0.25 | SDHC SDHD | Enlarged polycystic ovaries |
  HP:0040196 | 0.020501074829 | 0.25 | SDHA SDHD | Mild microcephaly |
  HP:0032263 | 0.0265783442433 | 0.5 | SDHAF2 SDHD SDHA SDHC | Increased blood pressure |
  HP:0001608 | 0.0265783442433 | 0.5 | SDHAF2 SDHD SDHA SDHC | Abnormality of the voice |
  HP:0100879 | 0.0270195830756 | 0.25 | SDHC SDHD | Enlarged ovaries |
  KEGG:05014 | 0.0275508352385 | 0.375 | SDHD SDHA SDHC | Amyotrophic lateral sclerosis |
  HP:0002034 | 0.0278991450986 | 0.375 | SDHD SDHA SDHC | Abnormal rectum morphology |
  HP:0000525 | 0.0279568393508 | 0.5 | SDHAF2 SDHD SDHA SDHC | Abnormality iris morphology |
  HP:0012378 | 0.0288088693347 | 0.5 | SDHAF2 SDHD SDHA SDHC | Fatigue |
  HP:5200230 | 0.0305702810662 | 0.5 | SDHAF2 SDHD SDHA SDHC | Maladaptive fear-related cognitions |
  HP:0000739 | 0.0305702810662 | 0.5 | SDHAF2 SDHD SDHA SDHC | Anxiety |
  HP:0011166 | 0.0306138099712 | 0.25 | SDHA SDHD | Focal myoclonic seizure |
  HP:0031192 | 0.0306138099712 | 0.25 | SDHA SDHD | Abnormal morphology of left ventricular trabeculae |
  HP:0030682 | 0.0306138099712 | 0.25 | SDHA SDHD | Left ventricular noncompaction |
  HP:0007083 | 0.0306138099712 | 0.25 | SDHA SDHD | Hyperactive patellar reflex |
  KEGG:05010 | 0.0317191137546 | 0.375 | SDHD SDHA SDHC | Alzheimer disease |
  HP:0008056 | 0.0327243470758 | 0.5 | SDHAF2 SDHD SDHA SDHC | Aplasia/Hypoplasia affecting the eye |
  HP:0030681 | 0.0344311064357 | 0.25 | SDHA SDHD | Abnormal morphology of myocardial trabeculae |
  GO:0009060 | 0.0351826169143 | 0.5 | SDHAF2 SDHD SDHA SDHC | aerobic respiration |
  HP:5200401 | 0.0356560220293 | 0.5 | SDHAF2 SDHD SDHA SDHC | Abnormal judgment |
  HP:0002239 | 0.0375873282395 | 0.375 | SDHD SDHA SDHC | Gastrointestinal hemorrhage |
  HP:0011675 | 0.0377152211096 | 0.5 | SDHAF2 SDHD SDHA SDHC | Arrhythmia |
  GO:0008177 | 0.0393180950424 | 0.25 | SDHA SDHD | succinate dehydrogenase (quinone) activity |
  GO:0000104 | 0.0393180950424 | 0.25 | SDHA SDHD | succinate dehydrogenase activity |
  HP:0011343 | 0.0427341718023 | 0.25 | SDHA SDHD | Moderate global developmental delay |
  HP:0030972 | 0.0436351567714 | 0.5 | SDHAF2 SDHD SDHA SDHC | Abnormal systemic blood pressure |
  HP:0006801 | 0.0472195728067 | 0.25 | SDHA SDHD | Hyperactive deep tendon reflexes |
  HP:0001892 | 0.0476665887161 | 0.5 | SDHAF2 SDHD SDHA SDHC | Abnormal bleeding |
Edges
Protein 1 | Protein 2 | Score | ProteomeHD | Interface Overlap | Evidence |
---|---|---|---|---|---|
 SDHA |  SDHB | 0.999 | 0.924           |
structurally_consistent (dimer)        
|
bioplex3_HEK293     bioplex ()     bioplex_WMM     Guru     bioplex3_WMM     boldt     youn_WMM     bioplex3_HCT116     fraction     boldt_WMM     |
 SDHAF2 |  SDHA | 0.999 | 0.088           |
mutually_exclusive (P21912)        
structurally_consistent (dimer)         |
hein_WMM     bioplex3_HEK293     bioplex ()     bioplex_WMM     bioplex3_WMM     hein ()     bioplex3_HCT116     |
 DHODH |  TMEM95 | 0.999 |            |          | bioplex3_HEK293     bioplex3_WMM     bioplex3_HCT116     WMM_only     |
 SDHC |  SDHD | 0.998 | 0.922           |
mutually_exclusive (Q02127)        
|
bioplex3_HEK293     bioplex3_WMM     bioplex3_HCT116     WMM_only     |
 DHODH |  SDHD | 0.998 | 0.122           |
structurally_consistent (dimer)        
|
bioplex3_HEK293     bioplex3_WMM     bioplex3_HCT116     WMM_only     |
 SDHAF4 |  SDHA | 0.997 | 0.07           |
mutually_exclusive (P21912)        
|
bioplex3_HEK293     bioplex ()     bioplex_WMM     bioplex3_WMM     bioplex3_HCT116     fraction     |
 SDHB |  SDHAF3 | 0.997 | 0.046           |
structurally_consistent (dimer)        
|
bioplex3_HEK293     bioplex ()     bioplex_WMM     bioplex3_WMM     |
 SDHC |  DHODH | 0.987 | 0.086           |
structurally_consistent (dimer)        
|
bioplex3_WMM     bioplex3_HCT116     WMM_only     |
 TMEM95 |  SDHD | 0.977 |            |          | bioplex3_HEK293     bioplex3_WMM     WMM_only     |
 SDHAF4 |  SDHAF3 | 0.972 | 0.104           |          | bioplex3_HEK293     bioplex ()     bioplex_WMM     bioplex3_WMM     |
 SDHB |  SDHD | 0.97 | 0.974           |
structurally_consistent (dimer)        
|
bioplex3_HEK293     bioplex3_WMM     bioplex3_HCT116     WMM_only     |
 HGF |  SDHB | 0.961 |            |          | bioplex3_HEK293     bioplex ()     bioplex_WMM     bioplex3_WMM     bioplex3_HCT116     |
 SDHA |  SDHD | 0.944 | 0.786           |
structurally_consistent (P21912)        
|
bioplex3_HEK293     bioplex3_WMM     bioplex3_HCT116     WMM_only     |
 SDHB |  SDHC | 0.938 | 0.91           |
structurally_consistent (dimer)        
|
bioplex3_HEK293     bioplex ()     bioplex_WMM     bioplex3_WMM     bioplex3_HCT116     fraction     |
 SDHA |  HGF | 0.928 |            |          | bioplex3_HEK293     bioplex ()     bioplex_WMM     bioplex3_WMM     bioplex3_HCT116     |
 SDHAF2 |  SDHAF4 | 0.911 | 0.058           |          | bioplex_WMM     bioplex3_WMM     WMM_only     |
 SDHA |  SDHC | 0.859 | 0.804           |          | bioplex3_HEK293     bioplex ()     bioplex_WMM     bioplex3_WMM     bioplex3_HCT116     gupta_WMM     fraction     |
 SDHA |  SDHAF3 | 0.832 | 0.104           |          | bioplex3_HEK293     bioplex ()     bioplex_WMM     bioplex3_WMM     |
 SDHAF4 |  SDHB | 0.732 | 0.062           |
structurally_consistent (dimer)        
|
bioplex_WMM     bioplex3_WMM     WMM_only     |
 SDHAF2 |  SDHB | 0.728 | 0.09           |
mutually_exclusive (P31040)        
structurally_consistent (dimer)         |
bioplex_WMM     bioplex3_WMM     WMM_only     |
 SDHAF2 |  SDHAF3 | 0.572 | 0.072           |          | bioplex_WMM     bioplex3_WMM     WMM_only     |
 SDHA |  DHODH | 0.255 | 0.088           |          | bioplex3_WMM     WMM_only     |
 SDHB |  DHODH | 0.223 | 0.144           |          | bioplex3_WMM     WMM_only     |
 SDHB |  TMEM95 | 0.006 |            |          | bioplex3_HEK293     bioplex3_HCT116     WMM_only     |
 SDHA |  TMEM95 | 0.002 |            |          | bioplex3_HEK293     bioplex3_HCT116     WMM_only     |
Related Complexes